Ethyl 2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetate, 95.0%, 5g

5-BROMOPYRAZOLO[1,5-A]PYRIDINE-2-CARBOXYLIC ACID, 95.0%, 100mg

Fmoc-D-Val-OH, 99.00%, 25g

5-(3,4,5-Trimethoxy-phenyl)-[1,3,4]oxadiazole-2-thiol, 5g

2,4-Dichloro-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine hydrochloride, 95.0%, 1g

1-(4-Fluorophenyl)piperazin-2-one, 95.0%, 1g

1-(1H-INDOL-7-YL)ETHANONE, 95.0%, 1g

2-Morpholinonicotinic acid, 95.0%, 25g

6-CHLORO-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE-2-CARBOXYLIC ACID, 97.0%, 250mg

Sodium thiosulphate anhydrous, min. 99%, pa, anhydrous, 250 g, plastic packaging.

1-Bromo-3-(diethoxymethyl)benzene, 95.0%, 100g

3-Chloro-5-nitropicolinic acid, 95.0%, 2.5g

2H-Imidazo[4,5-c]quinolin-2-one, 7-(3,5-dimethyl-4-isoxazolyl)-1,3-dihydro-8-methoxy-1-[(1R)-1-(2-pyridinyl)ethyl]-, 98%, 1mg